Please assess the completion status of the following clinical trial:

Trial Title: Pipeline for Uncoilable or Failed Aneurysms

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21 to 75 years, inclusive~* Patient has a single target IA in the anterior or posterior circulation that:~  a) Is located in the following regions of the internal carotid artery: i. Paraophthalmic (including paraclinoid, ophthalmic and hypophyseal segments) ii. Cavernous iii. Petrous~  b) Has a neck \>4 mm or no discernible neck AND a size (maximum fundus diameter) \>10 mm~  c) Has a parent vessel with diameter 2.5 - 5.0 mm distal/proximal to the target IA~* Subject has provided written informed consent using the Institutional Review Board (IRB)-approved consent form~* Subject has the necessary mental capacity to participate and is willing and able to comply with protocol requirements~Exclusion Criteria:~* More than one IA requires treatment in the next 6 months~* Subarachnoid hemorrhage from target IA in the past 60 days~* Unstable neurologic deficit (i.e., any worsening of clinical condition in the last 30 days)~* Irreversible bleeding disorder~* Platelet count \< 100 x 103 cells/mm3 or known platelet dysfunction~* Inability to tolerate, documented evidence of adverse reaction or contraindication to study medications~* Stent in place at the target IA~* Contraindication to CT scan or MRI~* Allergy to contrast used in angiography that cannot be medically controlled~* Known severe allergy to platinum or cobalt/chromium alloys~* Relative contraindication to angiography (e.g., serum creatinine \> 2.5 mg/dL)~* Woman of child-bearing potential who cannot provide a negative pregnancy test~* Evidence of active infection at the time of treatment~* Other conditions of the heart, blood, brain or intracranial vessels that carry a high risk of neurologic events (e.g., severe heart failure, atrial fibrillation, known carotid stenosis)~* Any comorbid disease or condition expected to compromise survival or ability to complete follow-up assessments to 180 days~* Extracranial stenosis greater than 50% in the carotid artery for anterior circulation aneurysms~* Intracranial stenosis greater than 50% in the treated vessel

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Pipeline (Type: EXPERIMENTAL): Placement of Pipeline Embolization Device in the parent artery at the aneurysm location

Based on this trial design, predict the completion outcome and termination type (if applicable).